These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8112966)

  • 1. Vitreoretinal toxicity of basic fibroblast growth factor.
    Borhani H; Peyman GA; Rahimy MH; Beuerman RW
    Int Ophthalmol; 1993 Aug; 17(4):195-9. PubMed ID: 8112966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aclacinomycin A in the treatment of experimental proliferative vitreoretinopathy. Efficacy and toxicity in the rabbit eye.
    Steinhorst UH; Chen EP; Hatchell DL; Samsa GP; Saloupis PT; Westendorf J; Machemer R
    Invest Ophthalmol Vis Sci; 1993 Apr; 34(5):1753-60. PubMed ID: 8473115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye.
    Borhani H; Rahimy MH; Peyman GA
    Ophthalmic Surg; 1994 Mar; 25(3):166-9. PubMed ID: 8196921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N,N-dimethyladriamycin for treatment of experimental proliferative vitreoretinopathy: efficacy and toxicity on the rabbit retina.
    Steinhorst UH; Chen EP; Machemer R; Hatchell DL
    Exp Eye Res; 1993 Apr; 56(4):489-95. PubMed ID: 8500561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular toxicity of intravitreal clarithromycin.
    Unal M; Peyman GA; Liang C; Hegazy H; Molinari LC; Chen J; Brun S; Tarcha PJ
    Retina; 1999; 19(5):442-6. PubMed ID: 10546942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy.
    Moritera T; Ogura Y; Yoshimura N; Honda Y; Wada R; Hyon SH; Ikada Y
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3125-30. PubMed ID: 1399416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes.
    Baldinger J; Doft BH; Burns SA; Johnson B
    Br J Ophthalmol; 1986 Sep; 70(9):657-61. PubMed ID: 3756121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of experimental proliferative vitreoretinopathy in the rabbit eye by intravitreal injections of fibroblast growth factor.
    Baudouin C; Fredj-Reygrobellet D; Ettaiche M; Barritault D; Gastaud P; Lapalus P
    Lens Eye Toxic Res; 1992; 9(3-4):505-11. PubMed ID: 1284520
    [No Abstract]   [Full Text] [Related]  

  • 11. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
    Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
    Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of vitreolysis and vitreous detachment with hyaluronidase and perfluoropropane gas.
    Kang SW; Hyung SM; Choi MY; Lee J
    Korean J Ophthalmol; 1995 Dec; 9(2):69-78. PubMed ID: 8818320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of enzymatic posterior vitreous detachment by intravitreal injection of hyaluronidase.
    Harooni M; McMillan T; Refojo M
    Retina; 1998; 18(1):16-22. PubMed ID: 9502276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of plasminogen-urokinase combination in inducing posterior vitreous detachment.
    Unal M; Peyman GA
    Retina; 2000; 20(1):69-75. PubMed ID: 10696751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit.
    Santana M; Wiedemann P; Kirmani M; Minckler DS; Patterson R; Sorgente N; Ryan SJ
    Graefes Arch Clin Exp Ophthalmol; 1984; 221(5):210-3. PubMed ID: 6489768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infliximab exerts a dose-dependent effect on retinal safety in the albino rabbit.
    Zayit-Soudry S; Vainer I; Zemel E; Mimouni M; Rabena M; Pieramici DJ; Perlman I; Loewenstein A
    Doc Ophthalmol; 2017 Dec; 135(3):175-185. PubMed ID: 28825191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of growth factor mRNA in rabbit PVR model systems.
    Planck SR; Andresevic J; Chen JC; Holmes DL; Rodden W; Westra I; Wu SC; Huang XN; Kay G; Wilson DJ
    Curr Eye Res; 1992 Nov; 11(11):1031-9. PubMed ID: 1282856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperthermia reduces the occurrence of proliferative vitreoretinopathy in a rabbit model.
    Yoshimura N; Kuriyama S; Ohuchi T; Takemura M; Honda Y; Hiraoka M
    Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):404-9. PubMed ID: 1740372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ocular pigmentation protects the rabbit retina from gentamicin-induced toxicity.
    Zemel E; Loewenstein A; Lei B; Lazar M; Perlman I
    Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1875-84. PubMed ID: 7635661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.